AdvisorShares Meidell Tactical Advantage ETF (MATH)

33.93
Delayed Data
As of Feb 21
 0.00 / 0.00%
Today’s Change
29.30
Today|||52-Week Range
35.56
+0.46%
Year-to-Date

Investment Objective

The investment seeks long-term capital appreciation with a secondary emphasis on capital preservation. The fund is considered a "fund of funds" that seeks to achieve its investment objective by primarily investing in other exchange-traded funds that offer diversified exposure to global regions- countries- styles (market capitalization- value- growth- etc.) or sectors- and other exchange-traded products. It primarily invests in U.S.-listed domestic and foreign equity- fixed income- and commodity ETPs. The Sub-Advisor uses a quantitative tactical methodology to identify the ETPs believed to be participating in long-term "durable trends" within the market.

No recent news for AdvisorShares Meidell Tactical Advantage ETF.

Performance

1 month-3.78% 3 years+2.82%
3 months+2.59% 5 years+4.75%
1 year+10.30% Since inception+4.85%
Data through 02/22/2018

Quote Details

Previous close$33.93
Open day’s range33.86 – 33.93
Net asset value (NAV)33.62 (02/21/2018)
Daily volume272
Average volume (3 months)1,295
Data as of 11:09am ET, 02/21/2018

Peer Comparisonvs. Tactical allocation ETFs

 MATHCategory
Performance 5-yr return+4.75%+5.36%
Expense Gross exp ratio2.28%1.61%
Risk 5 year sharpe ratio0.640.74
Net assets$14.8M$638.2M
Average market cap$9.3B$53.7B
Average P/E20.619.8
Dividend / Share--0.14%

Competitors

CPI IQ Real Return ETF

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
IJR iShares Core S&P Small-Cap ETF28.38%
IJH iShares Core S&P Mid-Cap ETF18.92%
EEM iShares MSCI Emerging Markets ETF10.09%
IBB iShares Nasdaq Biotechnology ETF9.81%
KRE SPDR® S&P Regional Banking ETF9.72%
XLF Financial Select Sector SPDR® Fund9.71%
IYH iShares U.S. Healthcare ETF9.63%